A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small cell lung cancer

被引：0
|
作者：
Bae, S.
Kim, M.
Shin, S.
Lee, K.
Hyun, M.
Song, H.
Kwon, K.
Park, K.
Lee, W.
机构：
[1] Catholic Univ Hosp, Taegu, South Korea
[2] Yeungnam Univ Hosp, Taegu, South Korea
[3] Keimyung Univ, Dongsan Hosp, Taegu, South Korea
[4] Dongguk Univ Hosp, Taegu, South Korea
[5] Fatima Hosp, Taegu, South Korea
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：338 / 338
页数：1
相关论文
共 50 条
  • [1] A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small cell lung cancer
    Lee, Won Silk
    Bae, Sung Hwa
    ANNALS OF ONCOLOGY, 2007, 18 : 183 - 184
  • [2] A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer
    Bae, Sung Hwa
    Ryoo, Hun Mo
    Do, Young Rok
    Song, Hong Suk
    Kwon, Ki Young
    Kim, Min Kyoung
    Lee, Kyung Hee
    Hyun, Myung Soo
    Lee, Won Sik
    Hur, In Kyong
    Baek, Jin Ho
    Park, Keon Uk
    LUNG CANCER, 2008, 59 (01) : 76 - 80
  • [3] A Phase II Study of Biweekly Irinotecan and Cisplatin for Patients With Extensive Stage Disease Small Cell Lung Cancer
    Ryoo, H.
    Bae, S.
    Hyun, M.
    Lee, K.
    Kim, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S623 - S623
  • [4] Phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive-stage small-cell lung cancer (WJTOG 0301)
    Iwamoto, Y.
    Kobayashi, M.
    Matsui, K.
    Yamamoto, H.
    Yamazaki, K.
    Saka, H.
    Sawa, T.
    Shibata, K.
    Takeda, K.
    Nakagawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] PHASE II STUDY OF IRINOTECAN PLUS CISPLATIN FOLLOWED BY AMRUBICIN IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (WJTOG 0301)
    Iwamoto, Y.
    Kobayashi, M.
    Matsui, K.
    Yamamoto, H.
    Yamazaki, K.
    Saka, H.
    Sawa, T.
    Shibata, K.
    Takeda, K.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 117
  • [6] Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer
    Hwang, Ki Eun
    Kim, So Young
    Jung, Jong Hoon
    Park, Seong Hoon
    Park, Jung Hyun
    Kim, Hwi Jung
    Kim, Hak Ryul
    Yang, Sei Hoon
    Jeong, Eun Taik
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2006, 61 (02) : 143 - 149
  • [7] Phase II study of Celecoxib with Cisplatin plus Etoposide in extensive-stage small cell lung cancer
    Araujo, Antonio M. F.
    Mendez, J. Carlos
    Sousa, Berta A.
    Barata, Fernando
    Figueiredo, Ana
    Azevedo, Isabel M.
    Amaro, Teresina
    Sousa, Maria J.
    Costa, Carla
    Lopes, J. MaChado
    ANNALS OF ONCOLOGY, 2004, 15 : 191 - 191
  • [8] Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer
    Araujo, Antonio M. F.
    Mendez, Jose C.
    Coelho, Ana L.
    Sousa, Berta
    Barata, Fernando
    Figueiredo, Ana
    Amaro, Teresina
    Azevedo, Isabel
    Soares, Marta
    CANCER INVESTIGATION, 2009, 27 (04) : 391 - 396
  • [9] Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer
    Araujo, Antonio M. F.
    Mendez, Jose C.
    Sousa, Berta
    Barata, Fernando
    Figueiredo, Ana
    Amaro, Teresina
    Coelho, Ana
    Azevedo, Isabel
    Soares, Marta
    ANNALS OF ONCOLOGY, 2006, 17 : 232 - 232
  • [10] Phase II Trial of Irinotecan plus Nedaplatin (INP) in Treating Patients with Extensive Stage Small Cell Lung Cancer
    Li, Chengguang
    Huang, Xin-En
    Li, Ying
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (02) : 487 - 490
12345